| Financial Year |
March 31 2023 |
| Monetary Funds |
1,064,500,064.11 |
| Held-for-trading Financial Assets |
14,103,286.36 |
| Notes Receivable |
30,202,913.64 |
| Accounts Receivable |
1,518,416,088.50 |
| Advances to Suppliers |
308,048,885.83 |
| Other Receivables |
67,272,505.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
84,303,054.80 |
| Total Current Assets |
3,087,808,173.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
185,111,857.82 |
| Investment Properties |
-- |
| Fixed Assetes |
343,938,152.61 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
224,981,156.72 |
| R&D expenses |
-- |
| Goodwill |
1,608,444,895.69 |
| Long-Term Deferred and Prepaid Expenses |
19,233,589.61 |
| Deferred Income Tax Assets |
18,120,969.97 |
| Other Non-Current Assets |
139,263,503.35 |
| Sub-Total of Non-Current Assets |
2,732,209,970.59 |
| Total Assets |
5,820,018,144.00 |
| Short-Term Loans |
1,412,464,110.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
19,948,467.00 |
| Accounts Payable |
463,376,946.61 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,225,185.33 |
| Taxes Payable |
8,068,019.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,326,197.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
122,350,122.82 |
| Sub-Total of Current Liabilities |
2,158,017,445.43 |
| Long-term Loans |
201,463,931.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,769,977.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
226,327,439.36 |
| Total Liabilities |
2,384,344,884.79 |
| Paid-In Capital(Or Share Stock) |
802,196,280.00 |
| Capital Surplus |
2,432,425,257.37 |
| Surplus Reserve |
144,016,876.56 |
| LESS:Treasury Stock |
120,572,700.15 |
| Undistributed Profits |
174,831,969.65 |
| Minority Stockholder's Interest |
-814,376.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,436,487,635.77 |
| Owner's Equity（Stockholder's Equity） |
3,435,673,259.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,820,018,144.00 |
